SANOFI — Sanofi India Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeMid CapHigh Flyer

Annual income statement for Sanofi India, fiscal year end - December 31st, INR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	29,019	29,566	27,701	19,961	20,132
Cost of Revenue
Gross Profit	16,103	16,253	15,577	10,286	10,158
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	23,098	17,715	19,891	15,490	15,971
Operating Profit	5,921	11,851	7,810	4,471	4,161
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	6,772	12,576	8,643	5,285	4,314
Provision for Income Taxes
Net Income After Taxes	4,776	9,444	6,206	3,646	3,137
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	4,776	9,444	6,206	6,029	4,133
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	4,776	9,444	6,206	6,029	4,133
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	221	248	229	153	148
Dividends per Share
Special Dividends per Share